UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code:
(
Former name or former address, if changed since last report: N/A
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | o |
Section 5 – Corporate Governance and Management
Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
(b) As previously disclosed on February 3, 2020, Mark T. Bertolini will not be nominated for re-election to the Board of Directors (the “Board”) of CVS Health Corporation (“CVS Health”) at the 2020 Annual Meeting of Stockholders. On February 7, 2020, Mr. Bertolini informed the Board of his decision to resign from the Board, effective immediately.
Section 9 – Financial Statements and Exhibits
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
The exhibit to this Current Report on Form 8-K is as follows:
INDEX TO EXHIBITS
104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CVS HEALTH CORPORATION | ||
Date: February 7, 2020 | By: | /s/ Colleen M. McIntosh |
Colleen M. McIntosh | ||
Senior Vice President and Corporate Secretary |
$#%<22<) AB^N[BO*T,Z%!.:H;MR(9"IYUTS7B*QX^M4] NT[4Y4'P2$,FD
MEU!#JSKK$ ;>3WN- KX
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M7@@OE_%J"+<$/D>M_*DNE!:*[&)=P:.,=S07Z4#5@#FM5W#@??LN'MROCT=?\\S8\$JY0
M8SGM4(N9+SC'\RYI#2XA1%!='H$S>\TQ;6$^U@Y<;YR/8TVGP'Z7LFCA#\X=
MX=OS_C"7ZV_-!
7-@]NQ0N>X6;I^;X8SU /%_KZ@)@2"HA%+L[
M\PZ!1.B%FI3VNI_6TPP/]D_4C5RT;C1LVZ7L50W)F\:->C:I=#*#GZDA2]R]
MJB?+N?0;5"9#D]D]93V5\6%_LLIL?&PF% B]-(DR2#NMJ$,^W%K\M F&6_R]
MEQF7CV.*L^.8X?UE'] KRI<@W[$\T\%K*]Y9'65 %$CR[>@:>QU6Q<*'LLID
M7M^V)\.NJ>_%K72LPV@V/V/47_Q8 OVP<33]4Q)
.H)S'1&?1&("8G@N2'K.![,>=%#(\='E\Q4??TEUG/7H(PK8>_R43]-<#J
MUV5?4$L#!!0 ( $R)1U +C]@#(0$ %<$ 3 6T-O;G1E;G1?5'EP
M97-=+GAM;+5434_#, S]*U.O:,W@P %MNP!7F 1_("1N&S5?LKW1_7O<;D-B
M*F)HVR6)\^SW7A(K\_=M!IITP4=:% US?E"*3 -!4YDR1$&JA$&SA%BKK$VK
M:U!WL]F],BDR1)YRSU$LYT]0Z;7GR>-NOZ=>%#IG[XQFEZ+:1'M$.MT3E@A^
MR*'&9;J1A&+RW D+R=ZB$)0*=8+"<6$?2]WK!A"=A7]92U7E#-ADUD%*2LH(
MVE(#P,&7U&@$^\;H8KWWN]+(+SH(L>J\^I%07L\';SV,&QB02RJSM 6,20W
M;KP]2_#0#28A3#,*BNQ&CB>65H*2ZA,O>43H6\>"/4E
Cover |
Feb. 07, 2020 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Feb. 07, 2020 |
Entity File Number | 001-01011 |
Entity Registrant Name | CVS HEALTH CORPORATION |
Entity Central Index Key | 0000064803 |
Entity Tax Identification Number | 05-0494040 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | One CVS Drive |
Entity Address, City or Town | Woonsocket |
Entity Address, State or Province | RI |
Entity Address, Postal Zip Code | 02895 |
City Area Code | 401 |
Local Phone Number | 765-1500 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, par value $0.01 per share |
Trading Symbol | CVS |
Security Exchange Name | NYSE |
Entity Emerging Growth Company | false |